4.5 Article

SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

The SUMO pathway in pancreatic cancer: insights and inhibition

Christian Schneeweis et al.

Summary: There is an urgent need to develop novel treatment strategies for patients with pancreatic ductal adenocarcinoma (PDAC); However, despite various efforts, novel targeted or specific therapies have not been established; Research suggests that the SUMO pathway plays a role in PDAC, particularly in connection to a subtype of the disease characterized by high MYC activity.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis

Garima Kaushik et al.

Summary: Pancreatic cancer stem cells (PCSC) play a crucial role in metastasis and therapy resistance of pancreatic cancer. The combination treatment of afatinib with gemcitabine shows promising results in targeting PCSCs and reducing tumor growth and metastasis. This novel mechanism involving the EGFR/ERK/FOXA2/SOX9 axis may provide a tailored approach to enhance chemotherapy efficacy in various cancer types.

ONCOGENE (2021)

Article Gastroenterology & Hepatology

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

Alexander Biederstadt et al.

Review Oncology

PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy

Yuwen Li et al.

TRENDS IN CANCER (2020)

Article Biochemistry & Molecular Biology

SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites

Liwen Zhou et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Biochemistry & Molecular Biology

SUMOylation in Glioblastoma: A Novel Therapeutic Target

Brandon M. Fox et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

PML hyposumoylation is responsible for the resistance of pancreatic cancer

Mirna Swayden et al.

FASEB JOURNAL (2019)

Review Medicine, Research & Experimental

The SUMO-specific protease family regulates cancer cell radiosensitivity

Chenxi Hu et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Oncology

PD2/PAF1 at the Crossroads of the Cancer Network

Saswati Karmakar et al.

CANCER RESEARCH (2018)

Article Gastroenterology & Hepatology

Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1

Rama Krishna Nimmakayala et al.

GASTROENTEROLOGY (2018)

Review Biochemistry & Molecular Biology

SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes

Xiaolan Zhao

MOLECULAR CELL (2018)

Review Biochemistry & Molecular Biology

Biological determinants of radioresistance and their remediation in pancreatic cancer

Parthasarathy Seshacharyulu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)

Review Medicine, Research & Experimental

Sumoylation Pathway as Potential Therapeutic Targets in Cancer

L. Gong et al.

CURRENT MOLECULAR MEDICINE (2016)

Article Biochemistry & Molecular Biology

SUMO modification regulates the protein stability of NDRG1

Jae Eun Lee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemical Research Methods

JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs

Guillaume Beauclair et al.

BIOINFORMATICS (2015)

Article Cell Biology

Global Reprogramming of Host SUMOylation during Influenza Virus Infection

Patricia Domingues et al.

CELL REPORTS (2015)

Review Biochemistry & Molecular Biology

PML-mediated signaling and its role in cancer stem cells

W. Zhou et al.

ONCOGENE (2014)

Article Multidisciplinary Sciences

Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling

Frederic Lamoliatte et al.

NATURE COMMUNICATIONS (2014)

Article Medicine, Research & Experimental

Inhibition of SENP1 induces radiosensitization in lung cancer cells

Ruo-Tian Wang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)

Article Oncology

Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines

Margaret A. Tempero et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)

Article Medicine, General & Internal

Pancreatic cancer

Audrey Vincent et al.

LANCET (2011)

Review Cell Biology

Concepts in sumoylation: a decade on

Ruth Geiss-Friedlander et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

The mechanisms of PML-nuclear body formation

Tian Huai Shen et al.

MOLECULAR CELL (2006)

Article Hematology

Role of SUMO-1-modified PML in nuclear body formation

S Zhong et al.

BLOOD (2000)